Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onno W Akkerman

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
The American Journal of Tropical Medicine and Hygiene|January 13, 2016
Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant EnterobacteriaceaeMatthias I Gröschel, Till F Omansen, Wiel de Lange, et al.
The European Respiratory Journal|March 25, 2016
Implementing tuberculosis entry screening for asylum seekers: the Groningen experienceOnno W Akkerman, Wiel C M de Lange, Elisabeth H Schölvinck, et al.
Expert Review of Anti-Infective Therapy|October 21, 2016
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkersJan-Willem C Alffenaar, Onno W Akkerman, Richard M Anthony, et al.
The European Respiratory Journal|December 3, 2013
Drug concentration in lung tissue in multidrug-resistant tuberculosisOnno W Akkerman, Richard van Altena, Theo Klinkenberg, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2020
The pharmacokinetics of antibiotics in cystic fibrosisAnne M Akkerman-Nijland, Onno W Akkerman, Floris Grasmeijer, et al.
International Journal of Mycobacteriology|January 4, 2017
Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoringMathieu S Bolhuis, Onno W Akkerman, Marieke G G Sturkenboom, et al.
The European Respiratory Journal|August 24, 2019
Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsulesMathieu S Bolhuis, Tjip S van der Werf, Huib A M Kerstjens, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 10, 2016
Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurementsMarieke G G Sturkenboom, Mathieu S Bolhuis, Onno W Akkerman, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2015
Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the futureMarieke G G Sturkenboom, Onno W Akkerman, Mathieu S Bolhuis, et al.
The European Respiratory Journal|May 22, 2019
Impact of radiographic screening of >34 000 asylum seeker childrenBert A Wolters, Onno W Akkerman, Yvonne Aartsma, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
The American Journal of Tropical Medicine and Hygiene|January 13, 2016
Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant EnterobacteriaceaeMatthias I Gröschel, Till F Omansen, Wiel de Lange, et al.
The European Respiratory Journal|March 25, 2016
Implementing tuberculosis entry screening for asylum seekers: the Groningen experienceOnno W Akkerman, Wiel C M de Lange, Elisabeth H Schölvinck, et al.
Expert Review of Anti-Infective Therapy|October 21, 2016
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkersJan-Willem C Alffenaar, Onno W Akkerman, Richard M Anthony, et al.
The European Respiratory Journal|December 3, 2013
Drug concentration in lung tissue in multidrug-resistant tuberculosisOnno W Akkerman, Richard van Altena, Theo Klinkenberg, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2020
The pharmacokinetics of antibiotics in cystic fibrosisAnne M Akkerman-Nijland, Onno W Akkerman, Floris Grasmeijer, et al.
International Journal of Mycobacteriology|January 4, 2017
Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoringMathieu S Bolhuis, Onno W Akkerman, Marieke G G Sturkenboom, et al.
The European Respiratory Journal|August 24, 2019
Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsulesMathieu S Bolhuis, Tjip S van der Werf, Huib A M Kerstjens, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 10, 2016
Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurementsMarieke G G Sturkenboom, Mathieu S Bolhuis, Onno W Akkerman, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2015
Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the futureMarieke G G Sturkenboom, Onno W Akkerman, Mathieu S Bolhuis, et al.
The European Respiratory Journal|May 22, 2019
Impact of radiographic screening of >34 000 asylum seeker childrenBert A Wolters, Onno W Akkerman, Yvonne Aartsma, et al.
Pageof 12